vTv Therapeutics Inc.
VTVT
$14.98
-$0.0161-0.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 35.24% | 103.21% | |||
| Gross Profit | -35.24% | -103.19% | |||
| SG&A Expenses | -1.50% | 37.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.73% | 32.47% | |||
| Operating Income | -18.73% | -32.93% | |||
| Income Before Tax | -18.71% | -40.12% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.71% | -40.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 18.58% | 40.10% | |||
| Net Income | -18.74% | -40.12% | |||
| EBIT | -18.73% | -32.93% | |||
| EBITDA | -18.85% | -33.35% | |||
| EPS Basic | -198.66% | -40.13% | |||
| Normalized Basic EPS | -198.69% | -40.13% | |||
| EPS Diluted | -198.66% | -40.13% | |||
| Normalized Diluted EPS | -198.69% | -40.13% | |||
| Average Basic Shares Outstanding | -60.24% | 0.00% | |||
| Average Diluted Shares Outstanding | -60.24% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||